Quantitative proteomic analysis of the hippocampus in the 5XFAD mouse model at early stages of Alzheimer's disease pathology

Journal of Alzheimer's Disease

Volumn 36, Issue 2, 2013, Pages 321-334

  Hong, Ingie ^a   Kang, Taewook ^b,c   Yoo, YongCheol ^c   Park, Royun ^d   Lee, Junuk ^a   Lee, Sukwon ^a   Kim, Jeongyeon ^a   Song, Boemjong ^a   Kim, Se Young ^c   Moon, Minho ^d   Yun, Ki Na ^c   Kim, Jin Young ^c   Mook Jung, Inhee ^d   Park, Young Mok ^b,c   Choi, Sukwoo ^a  

^a Seoul National University   (South Korea)

^b Chungnam National University   (South Korea)

^c Korea Basic Science Institute (KBSI)   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

Alzheimer's disease; amyloid ; memory; mild cognitive impairment; proteomics; PS1; transgenic mice

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; CLUSTERIN; GAMMA SECRETASE; MITOCHONDRIAL PROTEIN; NICASTRIN; OXIDOREDUCTASE; PROTEIN DISULFIDE ISOMERASE; PROTEIN P53; TRANSCRIPTION FACTOR NRF2; X BOX BINDING PROTEIN 1;

ALZHEIMER DISEASE; AMYLOID PLAQUE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CELLULAR DISTRIBUTION; CLEARANCE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; HIPPOCAMPUS; HUNTINGTON CHOREA; IMMUNOBLOTTING; INTRACELLULAR SIGNALING; MASS SPECTROMETRY; MOUSE; MUTATION; MYELIN SHEATH; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING;

EID: 84879627353     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-130311     Document Type: Article

References (57)

1. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3, 186-191 (Pubitemid 46825511)
2. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6, 734-746 (Pubitemid 47058377)
3. Ittner LM, Gotz J (2011) Amyloid-beta and tau-A toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci 12, 65-72
4. Citron M (2010) Alzheimer's disease: Strategies for disease modification. Nat Rev Drug Discov 9, 387-398
5. Selkoe DJ (2011) Resolving controversies on the path to Alzheimer's therapeutics. Nat Med 17, 1060-1065
6. Gandy S, Dekosky ST (2013) Toward the treatment and prevention of Alzheimer's disease: Rational strategies and recent progress. Annu Rev Med 64, 367-383
7. Petersen RC (2003) Mild cognitive impairment clinical trials. Nat Rev Drug Discov 2, 646-653 (Pubitemid 37361768)
8. Blennow K, Hampel H,Weiner M, Zetterberg H (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6, 131-144
9. Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, Aisen PS, Ghetti B, Klunk WE, McDade E, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Schofield PR, Sperling RA, Salloway S, Morris JC, Dominantly Inherited Alzheimer N (2012) Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 367, 795-804
10. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356 (Pubitemid 34790756)
11. Straub JE, Thirumalai D (2011) Toward a molecular theory of early and late events in monomer to amyloid fibril formation. Annu Rev Phys Chem 62, 437-463
12. De Strooper B, AnnaertW(2010) Novel research horizons for presenilins and gamma-secretases in cell biology and disease. Annu Rev Cell Dev Biol 26, 235-260
13. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, SmallGW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923 (Pubitemid 23275809)
14. Bu G (2009) Apolipoprotein E and its receptors in Alzheimer's disease: Pathways, pathogenesis and therapy. Nat Rev Neurosci 10, 333-344
15. Griffin WS, Sheng JG, Roberts GW, Mrak RE (1995) Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution. J Neuropathol Exp Neurol 54, 276-281
16. Sheng JG, Mrak RE, Griffin WS (1997) Glial-neuronal interactions in Alzheimer disease: Progressive association of IL-1alpha+ microglia and S100beta+astrocytes with neurofibrillary tangle stages. J Neuropathol Exp Neurol 56, 285-290 (Pubitemid 27461169)
17. Bantscheff M, Schirle M, Sweetman G, Rick J, Kuster B (2007) Quantitative mass spectrometry in proteomics: A critical review. Anal Bioanal Chem 389, 1017-1031 (Pubitemid 47482251)
18. Domon B, Aebersold R (2010) Options and considerations when selecting a quantitative proteomics strategy. Nat Biotechnol 28, 710-721
19. Cox J, Mann M (2011) Quantitative, high-resolution proteomics for data-Driven systems biology. Annu Rev Biochem 80, 273-299
20. Zhang J, Goodlett DR, Quinn JF, Peskind E, Kaye JA, Zhou Y, Pan C, Yi E, Eng J, Wang Q, Aebersold RH, Montine TJ (2005) Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease. J Alzheimers Dis 7, 125-133. discussion 173-180
21. Schonberger SJ, Edgar PF, Kydd R, Faull RL, Cooper GJ (2001) Proteomic analysis of the brain in Alzheimer's disease: Molecular phenotype of a complex disease process. Proteomics 1, 1519-1528 (Pubitemid 33587909)
22. Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, Berry R, Vassar R (2006) Intraneuronal beta-Amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: Potential factors in amyloid plaque formation. J Neurosci 26, 10129-10140 (Pubitemid 44527407)
23. Moon M, Hong HS, Nam DW, Baik SH, Song H, Kook SY, Kim YS, Lee J, Mook-Jung I (2012) Intracellular amyloid-beta accumulation in calcium-binding proteindeficient neurons leads to amyloid-beta plaque formation in animal model of Alzheimer's disease. J Alzheimers Dis 29, 615-628
24. Kimura R, Ohno M (2009) Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model. Neurobiol Dis 33, 229-235
25. Kim KH, Moon M,Yu SB, Mook-Jung I, Kim JI (2012)RNASeq analysis of frontal cortex and cerebellum from 5XFAD mice at early stage of disease pathology. J Alzheimers Dis 29, 793-808
26. Kim J, Lee S, Park K, Hong I, Song B, Son G, Park H, Kim WR, Park E, Choe HK, Kim H, Lee C, Sun W, Kim K, Shin KS, Choi S (2007) Amygdala depotentiation and fear extinction. Proc Natl Acad Sci U S A 104, 20955-20960
27. Xu T, Venable JD, Park SK, Cociorva D, Lu B, Liao L, Wohlschlegel J, Hewel J, Yates JR (2006) ProLuCID, a fast and sensitive tandem mass spectra-based protein identification program. Mol Cell Proteomics 5, S174-S174
28. Washburn MP, Wolters D, Yates JR, 3rd (2001) Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 19, 242-247 (Pubitemid 32220565)
29. Byun K, Young Kim J, Bayarsaikhan E, Kim D, Jeong GB, Yun KN, Kyeong Min H, Kim SU, Yoo JS, Lee B (2012) Quantitative proteomic analysis reveals that lipopolysaccharide induces mitogen-Activated protein kinase-Dependent activation in human microglial cells. Electophoresis 33, 3756-3763
30. Li Z, Adams RM, Chourey K, Hurst GB, Hettich RL, Pan C (2012) Systematic comparison of label-free, metabolic labeling, and isobaric chemical labeling for quantitative proteomics on LTQ Orbitrap Velos. J Proteome Res 11, 1582-1590
31. CociorvaD,DLT,Yates JR (2007)Validation of tandem mass spectrometry database search results using DTASelect. Curr Protoc Bioinformatics Chapter 13, Unit 13 14
32. Park SK,Venable JD, Xu T, Liao L,Yates JR (2006)Atool for quantitative analysis of high-Throughput mass spectrometry data. Mol Cell Proteomics 5, S199-S199
33. Raso C, Cosentino C, Gaspari M, Malara N, Han X, McClatchy D, Park SK, Renne M, Vadala N, Prati U, Cuda G, Mollace V, Amato F, Yates JR, 3rd (2012) Characterization of breast cancer interstitial fluids byTmTlabeling, LTQ-orbitrap velos mass spectrometry, and pathway analysis. J Proteome Res 11, 3199-3210
34. Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists usingDAVID bioinformatics resources. Nat Protoc 4, 44-57
35. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P, Jensen LJ, von Mering C (2011) The STRING database in 2011: Functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39, D561-D568
36. DeMattos RB, Cirrito JR, Parsadanian M, May PC, O'Dell MA, Taylor JW, Harmony JA, Aronow BJ, Bales KR, Paul SM, Holtzman DM (2004) ApoE and clusterin cooperatively suppress Abeta levels and deposition: Evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron 41, 193-202 (Pubitemid 38125181)
37. Jiang Q, LeeCY,Mandrekar S,Wilkinson B, Cramer P, Zelcer N, Mann K, Lamb B,Willson TM, Collins JL, Richardson JC, Smith JD, Comery TA, Riddell D, Holtzman DM, Tontonoz P, Landreth GE (2008) ApoE promotes the proteolytic degradation of Abeta. Neuron 58, 681-693 (Pubitemid 351778466)
38. Yu G, Nishimura M, Arawaka S, Levitan D, Zhang L, Tandon A, Song YQ, Rogaeva E, Chen F, Kawarai T, Supala A, Levesque L, Yu H, Yang DS, Holmes E, Milman P, Liang Y, Zhang DM, Xu DH, Sato C, Rogaev E, Smith M, Janus C, Zhang Y, Aebersold R, Farrer LS, Sorbi S, Bruni A, Fraser P, St George-Hyslop P (2000) Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. Nature 407, 48-54
39. Stampfer MJ (2006) Cardiovascular disease and Alzheimer's disease: Common links. J Intern Med 260, 211-223 (Pubitemid 44253634)
40. Hooper C, Meimaridou E, Tavassoli M, Melino G, Lovestone S, Killick R (2007) p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells. Neurosci Lett 418, 34-37 (Pubitemid 46628854)
41. Vardy ER, Rice PJ, Bowie PC, Holmes JD, Grant PJ, Hooper NM (2007) Increased circulating insulin-Like growth factor-1 in late-onset Alzheimer's disease. J Alzheimers Dis 12, 285-290
42. Freude S, Schilbach K, Schubert M (2009) The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer's disease: From model organisms to human disease. Curr Alzheimer Res 6, 213-223
43. Moloney AM, Griffin RJ, Timmons S, O'Connor R, Ravid R, O'Neill C (2010) Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging 31, 224-243
44. Iwakoshi NN, Lee AH, Vallabhajosyula P, Otipoby KL, Rajewsky K, Glimcher LH (2003) Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1. Nat Immunol 4, 321-329 (Pubitemid 36432313)
45. Sato T, Diehl TS, Narayanan S, Funamoto S, Ihara Y, De Strooper B, Steiner H, Haass C, Wolfe MS (2007) Active gamma-secretase complexes contain only one of each component. J Biol Chem 282, 33985-33993 (Pubitemid 350159441)
46. Huang TT, Naeemuddin M, Elchuri S, Yamaguchi M, Kozy HM, Carlson EJ, Epstein CJ (2006) Genetic modifiers of the phenotype of mice deficient in mitochondrial superoxide dismutase. Hum Mol Genet 15, 1187-1194
47. Grant CM, MacIver FH, Dawes IW (1997) Mitochondrial function is required for resistance to oxidative stress in the yeast Saccharomyces cerevisiae. FEBS Lett 410, 219-222 (Pubitemid 27304068)
48. Gillardon F, RistW, Kussmaul L, Vogel J, BergM, Danzer K, Kraut N, Hengerer B (2007) Proteomic and functional alterations in brain mitochondria from Tg2576 mice occur before amyloid plaque deposition. Proteomics 7, 605-616 (Pubitemid 46362624)
49. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-Term potentiation in vivo. Nature 416, 535-539 (Pubitemid 34288854)
50. Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, MalinowR (2006)AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52, 831-843 (Pubitemid 44828454)
51. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8, 101-112 (Pubitemid 46432529)
52. Hong I, Kim J, Lee J, Park S, Song B, Kim J, An B, Park K, Lee HW, Lee S, Kim H, Park SH, Eom KD, Lee S, Choi S (2011) Reversible plasticity of fear memory-encoding amygdala synaptic circuits even after fear memory consolidation. PLoS One 6, e24260
53. Hong I, Kim J, Song B, Park K, Shin K, Eom KD, Han PL, Lee S, Choi S (2012) Fear conditioning occludes late-phase longterm potentiation at thalamic input synapses onto the lateral amygdala in rat brain slices. Neurosci Lett 506, 121-125
54. Hong I, Song B, Lee S, Kim J, Choi S (2009) Extinction of cued fear memory involves a distinct form of depotentiation at cortical input synapses onto the lateral amygdala. Eur J Neurosci 30, 2089-2099
55. Pascoli V, Turiault M, Luscher C (2012) Reversal of cocaineevoked synaptic potentiation resets drug-induced adaptive behaviour. Nature 481, 71-75
56. Hong I, Kim J, Song B, Park S, Lee J, Kim J, An B, Lee S, Choi S (2011) Modulation of fear memory by retrieval and extinction: A clue for memory deconsolidation. Rev Neurosci 22, 205-229
57. Kim J, Song B, Hong I, Lee J, Park S, Eom JY, Lee CJ, Lee S, Choi S (2010) Reactivation of fear memory renders consolidated amygdala synapses labile. J Neurosci 30, 9631-9640